| 臺大學術典藏 |
2022-09-07T06:49:54Z |
Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of Helicobacter pylori in the community and hospital populations: A randomised trial
|
Liou J.-M.; Chen C.-C.; Chang C.-Y.; Chen M.-J.; Chen C.-C.; Fang Y.-J.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Liou T.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; Chang C.-C.; Bair M.-J.; Liu T.-Y.; Hsieh C.-F.; Tsao F.-Y.; Shun C.-T.; Lin J.-T.; YI-CHIA LEE; Wu M.-S.; the Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-09-07T06:49:53Z |
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
|
Liou J.-M.; Fang Y.-J.; Chen C.-C.; Bair M.-J.; Chang C.-Y.; YI-CHIA LEE; Chen M.-J.; Chen C.-C.; Tseng C.-H.; Hsu Y.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hu W.-H.; Chen Y.-N.; Sheu B.-S.; Lin J.-T.; Wu J.-Y.; El-Omar E.M.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-09-07T06:49:46Z |
14 Day sequential therapy versus 10 day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of Helicobacter pylori: A multicentre, non-inferiority, randomized trial
|
Liou J.-M.; Chen C.-C.; Fang Y.-J.; Chen P.-Y.; Chang C.-Y.; Chou C.-K.; Chen M.-J.; Tseng C.-H.; Lee J.-Y.; Yang T.-H.; Chiu M.-C.; Yu J.-J.; Kuo C.-C.; Luo J.-C.; Hsu W.-F.; Hu W.-H.; Tsai M.-H.; Lin J.-T.; Shun C.-T.; Twu G.; YI-CHIA LEE; Bair M.-J.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-09-07T06:49:45Z |
Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection
|
Liou J.-M.; Chen P.-Y.; Luo J.-C.; Lee J.-Y.; Chen C.-C.; Fang Y.-J.; Yang T.-H.; Chang C.-Y.; Bair M.-J.; Chen M.-J.; Hsu Y.-C.; Hsu W.-F.; Chang C.-C.; Lin J.-T.; Shun C.-T.; El-Omar E.M.; Wu M.-S.; Liou J.-M.; YI-CHIA LEE; Lin J.-T.; Wu C.-Y.; Wu J.-Y.; Chen C.-C.; Lin C.-H.; Fang Y.-R.; Bair M.-J.; Luo J.-C.; Cheng T.-Y.; Tseng P.-H.; Chiu H.-M.; Chang C.-C.; Yu C.-C.; Chiu M.-C.; Chen Y.-N.; Hu W.-H.; Chou C.-K.; Tai C.-M.; Lee C.-T.; Wang W.-L.; Chang W.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-09-07T06:49:42Z |
Serum pepsinogen as a predictor for gastric cancer death A 16-year community-based cohort study
|
Chiang T.-H.; Chiu S.Y.-H.; Chen S.L.-S.; Yen A.M.-F.; Fann J.C.-Y.; Liu C.-Y.; Chou C.-K.; Chiu H.-M.; Shun C.-T.; Wu M.-S.; Lin J.-T.; YI-CHIA LEE; Chen T.H.-H.; Lin M.-W. |
| 臺大學術典藏 |
2022-09-07T06:49:39Z |
Comparison of the effect of clarithromycin triple therapy with or without N-acetylcysteine in the eradication of Helicobacter pylori: a randomized controlled trial
|
Chen C.-C.; Luo J.-C.; Fang Y.-J.; Lee J.-Y.; Kuo C.-C.; Yang T.-H.; Chiu M.-C.; Yu J.-J.; Bair M.-J.; Chen P.-Y.; Chou C.-K.; Chen C.-Y.; Chang C.-Y.; Hsu Y.-C.; Tseng C.-H.; Hsu W.-F.; Hu W.-H.; Tsai M.-H.; Hsieh C.-L.; Chen M.-J.; Shun C.-T.; Liu T.-Y.; YI-CHIA LEE; Liou, J.-M.; Wu, M.-S.; and for the Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-09-07T06:49:36Z |
Mass eradication of Helicobacter pylori to reduce gastric cancer incidence and mortality: A long-term cohort study on Matsu Islands
|
Chiang T.-H.; Chang W.-J.; Chen S.L.-S.; Yen A.M.-F.; Fann J.C.-Y.; Chiu S.Y.-H.; Chen Y.-R.; Chuang S.-L.; Shieh C.-F.; Liu C.-Y.; Chiu H.-M.; Chiang H.; Shun C.-T.; Lin M.-W.; Wu M.-S.; Lin J.-T.; Chan C.-C.; Graham D.Y.; Chen H.-H.; YI-CHIA LEE |
| 臺大學術典藏 |
2022-09-07T06:49:35Z |
Risk stratification for gastric cancer after Helicobacter pylori eradication: A population-based study on Matsu Islands
|
Chiang T.-H.; Maeda M.; Yamada H.; Chan C.-C.; Chen S.L.-S.; Chiu S.Y.-H.; Chen Y.-N.; Chou Y.-H.; Shieh C.-F.; Liu C.-Y.; Chiu H.-M.; Chiang H.; Shun C.-T.; Lin M.-W.; Wu M.-S.; Lin J.-T.; Chen H.-H.; Ushijima T.; Graham D.Y.; YI-CHIA LEE |
| 臺大學術典藏 |
2022-09-07T06:49:35Z |
Bismuth salts with versus without acid suppression for Helicobacter pylori infection: A transmission electron microscope study
|
Chiang T.-H.; Chen C.-C.; Tseng P.-H.; Liou J.-M.; Wu M.-S.; Shun C.-T.; YI-CHIA LEE; Graham D.Y. |
| 臺大學術典藏 |
2022-09-07T06:49:30Z |
Brand interchangeability of pepsinogen tests in the real-world setting after eradication of Helicobacter pylori: a community-based study
|
Chiang T.-H.; Chen Y.-N.; Chen Y.-R.; Tseng Y.-H.; Shieh C.-F.; Liu C.-Y.; Chiu H.-M.; Chiang H.; Shun C.-T.; Wu M.-S.; Lin J.-T.; YI-CHIA LEE |
| 臺大學術典藏 |
2022-09-06T08:57:17Z |
Secular changes in the clinical manifestation and pathologic pattern of early gastric cancer in Taiwan.
|
Lin J.T.; MING-SHIANG WU; Wang J.T.; Chen K.M.; Wei T.C.; Shun C.T.; Chen C.J.; Wang H.P.; Chan T.M.; Wang T.H. |
| 臺大學術典藏 |
2022-09-06T08:57:15Z |
Microsatellite instability in gastric carcinoma with special references to histopathology and cancer stages
|
Lin J.-T.; MING-SHIANG WU; Shun C.-T.; Lee W.-J.; Wang J.-T.; Wang T.-H.; Sheu J.-C. |
| 臺大學術典藏 |
2022-09-06T08:57:14Z |
Coexistence of anomalous pancreaticobiliary ductal union with adenomyomatosis of the gallbladder
|
MING-SHIANG WU; Wang H.-P.; Shun C.-T.; Yu S.-C.; Wang T.-H.; Lin J.-T. |
| 臺大學術典藏 |
2022-09-06T08:57:14Z |
Occurrence of Microsatellite Instability in Gastric Carcinoma Is Associated with Enhanced Expression of erbB-2 Oncoprotein
|
Lin J.-T.; MING-SHIANG WU; Shun C.-T.; Lee W.-J.; Sheu J.-C.; Wang T.-H. |
| 臺大學術典藏 |
2022-09-06T08:57:12Z |
Intragenic homozygous deletions of MTS1 gene in gastric cancer in Taiwan
|
MING-SHIANG WU; Lin Y.-W.; Sheu J.-C.; Wang H.-P.; Wang J.-T.; Shun C.-T.; Lee W.-J.; Wang T.-H.; Lin J.-T. |
| 臺大學術典藏 |
2022-09-06T08:57:11Z |
Increased prevalence of Helicobacter pylori infection among patients affected with intestinal-type gastric cancer at non-cardiac locations
|
MING-SHIANG WU; Chen S.-Y.; Shun C.-T.; Lee W.-J.; Wang H.-P.; Wang T.-H.; Chen C.-J.; Lin J.-T. |
| 臺大學術典藏 |
2022-09-06T08:57:11Z |
Endoscopic ultrasonographic characteristics of a gastric tubular duplication
|
Wang K.-L.; Wang H.-P.; MING-SHIANG WU; Shun C.-T.; Lee P.-H.; Wang T.-H.; Lin J.- T. |
| 臺大學術典藏 |
2022-09-06T08:57:11Z |
Serum pepsinogen I, II, and the ratio of pepsinogen I / pepsinogen II in the intestinal metaplasia of the stomach
|
Chang S.-Y.; MING-SHIANG WU; Shun C.-T.; Wang H.-H.; Yang T.-H.; Liu C.-Y.; Lin J.- T. |
| 臺大學術典藏 |
2022-09-06T08:57:10Z |
Genetic alterations in gastric cancer: Relation to histological subtypes, tumor stage, and Helicobacter pylori infection
|
MING-SHIANG WU; Shun C.-T.; Wang H.-P.; Sheu J.-C.; Lee W.-J.; Wang T.-H.; Lin J.- T. |
| 臺大學術典藏 |
2022-09-06T08:57:10Z |
Relationship of mucopolysaccharide change, Helicobacter pylori infection and expression of P-53 in gastric cancer
|
Shun C.-T.; MING-SHIANG WU; Lee W.-J.; Lin J.-T.; Chuang S.-M. |
| 臺大學術典藏 |
2022-09-06T08:57:09Z |
Infrequent hMSH2 mutations in sporadic gastric adenocarcinoma with microsatellite instability
|
MING-SHIANG WU; Sheu J.-C.; Shun C.-T.; Lee W.-J.; Wang J.-T.; Wang T.-H.; Cheng A.-L.; Lin J.-T. |
| 臺大學術典藏 |
2022-09-06T08:57:08Z |
Loss of imprinting and overexpression of IGF2 gene in gastric adenocarcinoma
|
MING-SHIANG WU; Wang H.-P.; Lin C.-C.; Sheu J.-C.; Shun C.-T.; Lee W.-J.; Lin J.-T. |
| 臺大學術典藏 |
2022-09-06T08:57:08Z |
Relationship of p53 and c-erbB-2 expression to histopathological features, Helicobacter pylori infection and prognosis in gastric cancer
|
Shun C.-T.; MING-SHIANG WU; Lin J.-T.; Chen S.-Y.; Wang H.-P.; Lee W.-J.; Wang T.-H.; Chuang S.-M. |
| 臺大學術典藏 |
2022-09-06T08:57:08Z |
Distinct clinicopathologic characteristics of diffuse-and intestinal- type gastric cancer in Taiwan
|
MING-SHIANG WU; Yang K.-C.; Shun C.-T.; Hsiao T.-J.; Lin C.-C.; Wang H.-P.; Chuang S.-M.; Lee W.-J.; Lin J.-T. |
| 臺大學術典藏 |
2022-09-06T08:57:07Z |
Gastric cancer risk in relation to Helicobacter pylori infection and subtypes of Intestinal metaplasia
|
MING-SHIANG WU; Shun C.-T.; Lee W.-C.; Chen C.-J.; Wang H.-P.; Lee W.-J.; Sheu J.-C.; Lin J.-T. |
